Key facts
- It has raised $2.2M; the latest was Grant ($10K) in Sep 2025.
- Notable investors include Tech Incubator Program for Startup, FuturePlay, Deokin, Inwoo Hyung, J&P Medi Partners — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for ReadyCure
- ·The full record, as it builds
Funding rounds
No funding rounds for ReadyCure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ReadyCure
Developer of radiation therapy system designed for patients suffering from dementia. The company specializes in the treatment of Alzheimer's dementia using low-dose radiation technology that has anti-inflammatory and neuroprotective effects, enabling healthcare professionals to provide treatment resolutions to patients suffering from Alzheimer's and its related effects.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2021
- Employees
- 14
- Website
- ready-cure.com/
- Ownership
- Privately Held (backing)
ReadyCure doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ReadyCure shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ReadyCure in its N-PORT filings yet. We sweep new filings monthly.